Invasive Candidiasis
📧 Sign up to get email alerts when something new happens for Invasive Candidiasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: CRITIC - Treatment of Candidemia and Invasive Candidiasis [Phase 4]
Phase 4 clinical trial update for the CRITIC study evaluating treatment of candidemia and invasive candidiasis; the study sponsored by Gilea…
-
CLINICAL_TRIALS trial_result · 2009-03-24Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) [Phase 3]
A multicenter Phase 3 randomized trial compared two dosing regimens of an antifungal drug for invasive candidiasis; the study is completed a…
-
CLINICAL_TRIALS trial_result · 2008-10-21Clinical Trial Update: The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis [Phase 3]
This Phase 3 trial compares Anidulafungin with a comparator in patients with candidemia or invasive candidiasis to evaluate safety and effic…
-
CLINICAL_TRIALS trial_result · 2008-10-21Clinical Trial Update: The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. [Phase 2]
A Phase 2 trial evaluating intravenous anidulafungin for invasive candidiasis has completed. The study assessed safety and effectiveness in …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Anidulafungin Versus Fluconazole in the Treatment of Candidemia [Phase 3]
Phase 3 trial comparing anidulafungin to fluconazole for candidemia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-01-02Clinical Trial Update: Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia [Phase 3]
A Phase 3 trial comparing micafungin to fluconazole for invasive candidiasis and candidemia has completed.
-
FDA approval · 2007-08-06FDA Approved: MYCAMINE — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for MYCAMINE (micafungin sodium) by Astellas Pharma US, Inc.
-
FDA approval · 2006-08-07FDA Approved: ERAXIS — Supplemental Application (Roerig)
The FDA approved a supplemental application for ERAXIS (anidulafungin) submitted by Roerig.
-
FDA approval · 2006-06-27FDA Approved: MYCAMINE — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for MYCAMINE (micafungin sodium) from Astellas Pharma US, Inc., expanding labeling through a supplem…